Molecular Microbiology (2012) 85(3), 513â€“534 äŠ?                                                          doi:10.1111/j.1365-2958.2012.08124.x
                                                                                                         published online 12 July 2012



Phosphoglucomutase absent Trypanosoma brucei redundantly substituted phosphomannomutase phospho-N-acetylglucosamine mutase                                                  mmi_8124 513..534




Giulia Bandini,1â€  Karina MariÃ±o,1â€¡                                      enzymes. example organism M. Lucia Sampaio GÃ¼ther,1 Amy K. Wernimont,2                            PGM activity completely replaced way
Sabine Kuettel,1 Wei Qiu,2 Shamshad Afzal,1Â§                            explains  uniquely, T. brucei able
Anna Kelner,1 Raymond Hui2                                          lose PGM gene. RNAi data TbPMM Michael  J. Ferguson1*                                                showed essential gene parasite
1
 Division Biological Chemistry Drug Discovery,                   growth.
College Life Sciences, University Dundee, Dundee
DD1 5EH, UK.
2
 Structural Genomics Consortium, University Toronto,
                                                                        Introduction
Toronto, Ontario, Canada.                                               kinetoplastid Trypanosoma brucei causative
                                                                        agent human African trypanosomiasis, known                                                                         â€˜sleeping sicknessâ€™, cattle disease Nagana.
Summary                                                                 Human African trypanosomiasis fatal untreated     enzymes      phosphomannomutase       (PMM),                    constitutes major public health problem sub-
phospho-N-acetylglucosamine mutase (PAGM)                           Saharan Africa (Favre et al., 2008). disease char-
phosphoglucomutase (PGM) reversibly catalyse                        acterized asymptomatic period weeks transfer phosphate C6 C1 hydro-                      months progresses early stage, character-
xyl groups mannose, N-acetylglucosamine                          ized malaria-like symptoms, advanced stage,
glucose respectively. genes candidate                    severe neurological mental disorders appear.
PMM PAGM enzymes                           clear need new therapeutics control Trypanosoma brucei genome,  surprisingly,                      disease. candidate gene PGM. TbPMM TbPAGM                            Trypanosoma brucei related trypanosomatid
genes cloned expressed Escherichia coli                     parasites Trypanosoma cruzi Leishmania sp. synthe- TbPMM enzyme crystallized struc-                    size complex cell-surface glycoconjugates, ture solved 1.85 Ã… resolution. Antibodies                     essential parasite survival infectivity.
recombinant proteins localized endogenous TbPMM                         Examples infective bloodstream form T. brucei glycosomes bloodstream form parasite,                  include variant surface glycoprotein (VSG), trans- TbPAGM localized cytosol gly-                     ferrin receptor (Steverding et al., 1995; Cross, 1996;
cosomes. recombinant enzymes able                          Mehlert et al., 1998; Pays Nolan, 1998; Mehlert interconvert glucose-phosphates, acting                   Ferguson, 2007), p67 lysosomal glycoprotein (Peck definitive substrates. Analysis sugar                      et al., 2008) membrane-bound histidine acid phos-
nucleotide levels parasites TbPMM TbPAGM                     phatase TbMBAP1 (Engstler et al., 2005). led knocked RNA interference (RNAi) suggests                        investigation enzymes sugar nucleotide bio-  vivo, PGM activity catalysed                        synthesis potential therapeutic targets (Davis et al.,
                                                                        2004; Urbaniak et al., 2006a,b; Turnock Ferguson,
Accepted 2 June, 2012.  correspondence. E-mail m j.               2007; Turnock et al., 2007; Stokes et al., 2008; Denton
ferguson@dundee.ac.uk; Tel. (+44) 1382 384219; Fax (+44) 1382
386373. Present addresses: â€ Department Molecular Cell            et al., 2010; Lackovic et al., 2010; MariÃ±o et al., 2010;
Biology, Boston University, Henry Goldman School Dental Medi-        2011).
cine, Boston, MA 02118, USA; â€¡National Institute Bioprocessing         Sugar nucleotides activated forms sugars used
Research Training, Dublin-Oxford Glycobiology Laboratory,
Conway Institute, University College Dublin, Belfield, Dublin 4,        donors glycosylation reactions. synthe-
Ireland; Â§Division Gene Regulation Expression, College Life   sized novo pathway, requiring conver-
Sciences, University Dundee, Dundee DD1 5EH, UK.                     sion precursor sugar/sugar nucleotide, use article permitted accordance Terms Conditions set http://wileyonlinelibrary.com/onlineopen#     salvage pathway, sugar activated using OnlineOpen_Terms                                                        kinase pyrophosphorylase. eukaryotes,
Â© 2012 Blackwell Publishing  514 G. Bandini et al. äŠ?

                                                                                           Fig. 1. Biosynthesis UDP-GlcNAc,
                                                                                           UDP-Glc, UDP-Galp, GDP-Man GDP-Fuc
                                                                                           T. brucei. Glucose taken                                                                                            environment phosphorylated Glc-6-P,
                                                                                           starting point novo
                                                                                           synthesis sugar nucleotides. Glc-6-P                                                                                            normally converted Glc-1-P action                                                                                            PGM;  conventional PGM
                                                                                           homologue identified T. brucei.
                                                                                           Salvage pathways present                                                                                            biosynthesis GDP-Man UDP-GlcNAc
                                                                                           Man GlcN, UDP-Galp                                                                                            synthesized novo UDP-Glc
                                                                                           action UDP-galactose 4-epimerase.
                                                                                           metabolites enzymes referred                                                                                            paper marked black. HK,
                                                                                           hexokinase; PGI, glucose-6-phosphate
                                                                                           isomerase; GFAT,
                                                                                           glucosamine-fructose-6-phosphate
                                                                                           aminotransferase; GalE, UDP-galactose
                                                                                           4-epimerase; PMI, phosphomannose
                                                                                           isomerase; MPGT, GDP-mannose
                                                                                           pyrophosphorylase.




sugar nucleotides formed used cytosol                    calreticulin-mediated glycoprotein quality control transported lumen Golgi apparatus                   requires UDP-Glc donor substrate (Sousa endoplasmic reticulum used                 et al., 1992; Caramelo et al., 2004). T. brucei UGGT glycosyltransferases (Freeze Elbein, 2008).                         shown essential parasite growth survival
   years, knowledge T. brucei sugar              40Â°C (Izquierdo et al., 2009). UDP-Glc pre-
nucleotide biosynthesis (Fig. 1) widened demon-                  sumed donor synthesis base J (b-D-
strate steps biosynthesis GDP-fucose             glucosylhydroxymethyluracil), rare deoxynucleotide (GDP-Fuc) (Turnock et al., 2007), UDP-galactose (UDP-                   unknown function DNA trypanosomatids
Gal) (Roper et al., 2002; 2005; Urbaniak et al., 2006b),                (Borst Sabatini, 2008 references . Finally,
UDP-N-acetylglucosamine (UDP-GlcNAc) (Stokes et al.,                    action UDP-Glc 4â€²-epimerase, UDP-Glc 2008; MariÃ±o et al., 2011) GDP-mannose (GDP-Man)                    source essential sugar nucleotide UDP-Gal (Denton et al., 2010) essential parasite growth.                T. brucei T. cruzi (Roper et al., 2002; 2005; MacRae
Furthermore,  (MariÃ±o et al.,                   et al., 2006) hexose transporters 2010), reports enzymes sugar                   D-Gal (Barrett et al., 1995; Tetaud et al., 1996).
nucleotide biosynthesis located kinetoplastid                   Generally, UDP-Glc synthesized step
peroxisome-like organelle, glycosome.                               process:   phosphorylation glucose glucose-6-P    Despite advances, importance                      hexokinase, (ii) transfer phosphate group C6 metabolite, relatively little known synthesis           C1 produce glucose-1-phosphate (Glc-1-P) phos-
UDP-glucose (UDP-Glc) T. brucei. eukaryotic cells,                phoglucomutase (PGM, E.C. 5.4.2.2) (iii) coupling UDP-Glc required synthesis diverse glucose-               glucose-1-P UTP UDP-Glc pyrophosphorylase
containing glycoconjugates secondary metabolites                    (UGP). T. brucei, enzymes responsible (Flores-DÃ­az et al., 1997). plays crucial role         step characterized (Nwagwu â€˜quality controlâ€™ newly synthesized glycoproteins taking             Opperdoes, 1982; MariÃ±o et al., 2010) T. cruzi place endoplasmic reticulum (Trombetta Parodi,               Leishmania easily identifiable PGM genes (Penha
2003; Ruddock Molinari, 2006), unfolded glycopro-                et al., 2005; 2009). absence putative T. brucei
tein glucosyltransferase (UGGT), calnexin-                  PGM gene perplexing.

                                                                  Â© 2012 Blackwell Publishing  Molecular Microbiology, 85, 513â€“534
                                                                                      PMM, PAGM phosphoglucomutase activity T. brucei 515

   PGMs belong D-phosphohexomutase                    eukaryotic PMM family. Eukaryotic PMMs members (PHM) superfamily enzymes eukaryotic              haloacid dehydrogenase superfamily phosphotrans-
phospho-N-acetylglucosamine mutases (PAGM, E.C.                    ferases. TbPMM, like eukaryotic PMMs, belongs
5.4.2.3) bacterial phosphomannomutase/phospho-                 type II class superfamily (Kedzierski et al.,
glucomutases (PMM/PGM, E.C. 5.4.2.2) phospho-                  2006; Silvaggi et al., 2006). deduced glucosamine mutases (E.C. 5.4.2.10) (Shackelford et al.,           location cap domain (aa 85â€“183), class
2004). eukaryotic phosphomannomutases                     motif II III (Fig. 2A). Eukaryotic
(PMM, E.C. 5.4.2.8) reversibly catalyse transfer        PMMs characterized conserved DVDGT motif
phosphate group mannosyl phosphate                (motif  aa 9â€“13), localized protein N-terminus. C6 C1 positions, enzymes belong halo-             Asp motif (D9) phosphorylated acid dehydrogenase superfamily phosphotransferases              catalytic cycle. TbPMM shows 57  sequence identity (Collet et al., 1998).                                             S. cerevisiae homologue.
   apparent lack gene encoding T. brucei PGM             BLASTp search T. brucei predicted protein explained TbPGM bears little resemblance         database Homo sapiens S. cerevisiae PAGM conventional PGMs, conversion glucose-             amino acid sequences (NCBI accession nos. NP_
phosphates catalysed TbPMM TbPAGM.                056414.1 NP_010856.1 respectively) revealed likely  eukaryotic           single putative TbPAGM gene (GeneDB ID: Tb927.8.980)
PMMs PAGMs generally highly specific             (Turnock Ferguson, 2007). putative PAGMs
sugar phosphate substrates, ability PMMs           identified T. cruzi (GeneDB ID: TcCLB.
PAGMs interconvert glucose-phosphates                  503733.70, TcCLB.508569.80). genes shown (Fernandez-Sorensen Carlson, 1971; Boles                 97  identical, probably accounting hap-
et al., 1994; Hofmann et al., 1994; Oesterhelt et al., 1996;       lotypes (Esmeraldo non-Esmeraldo-like) present Pirard et al., 1997; 1999; Kato et al., 2005; Qian et al.,         CL-Brener strain sequenced (El-Sayed et al.,
2007).                                                             2005a). single PAGM gene detected    paper, identified genes encoding functional      L. major (GeneDB ID: LmjF07.0805). TbPAGM, T. brucei phosphomannomutase (TbPMM) phospho-                  predicted amino acid sequence contains conserved
N-acetylglucosamine mutase (TbPAGM) studied              motifs D-PHM family, phosphate-
subcellular location metabolic activities bloodstream       binding site (RPSGTE, aa 564â€“569), Mg2+ binding site
form T. brucei. interconverting mannose-            (DGDADR, aa 338â€“343), invariant resi-
N-acetylglucosamine-phosphates respectively,             dues R564, S566, G418, D338, D340, D342,
shown capable producing Glc-1-P glucose-             R343 (marked asterisks, Fig. 2B) (Shackelford et al.,
6-phosphate (Glc-6-P), albeit different efficiencies.         2004).  TbPAGM, sugar-binding site (aa
TbPMM crystallized structure solved            435â€“442) contains unusual variation, 
high resolution. dual specificities enzymes           mally highly conserved A437 residue replaced suggested explanation absence TbPGM                serine. observed PAGMs, phosphoserine
gene parasite knockdown TbPMM                   loop (TASHNP, aa 80â€“85, black box, Fig. 2B), essential
TbPAGM RNA interference (RNAi) showed                 catalytic activity, translocated earlier position
enzymes mutually redundant PGM activity.             compared PHM family members, order                                                                    accommodate bulky N-acetyl group present                                                                    phosphorylated GlcNAc substrate (Shackelford et al.,
Results                                                            2004). TbPAGM shares 28  35  identity                                                                    human yeast orthologues respectively.
Identification T. brucei PMM PAGM
                                                                      According recent quantitative proteomic analysis,
encoding genes
                                                                   TbPAGM TbPMM present protein level
Saccharomyces cerevisiae PMM (NCBI accession :                  life cycle stages relative concentrations NP116609) previously used template                  proteins (procyclic levels divided bloodstream form
BLASTp search T. brucei predicted proteins                  levels) 1.06 â«¾ 0.30 1.17 â«¾ 0.30 respectively
Tb10.70.0370 identified putative TbPMM. Puta-             (Urbaniak et al., 2012).
tive PMM genes Leishmania
major (GeneDB ID: LmjF36.1960) T. cruzi (GeneDB
                                                                   activities recombinant TbPMM TbPAGM ID: TcCLB.510187.480) genomes (Turnock Fergu-
                                                                   mannose- N-acetylglucosamine-phosphates
son, 2007) Leishmania mexicana PMM structurally characterized (LmxM.36.1960; Kedzierski               TbPMM TbPAGM open reading frames (ORFs)
et al., 2006). shown Fig. 2A, TbPMM belongs           amplified PCR genomic DNA obtained 
Â© 2012 Blackwell Publishing  Molecular Microbiology, 85, 513â€“534
 516 G. Bandini et al. äŠ?




Fig. 2. TbPMM TbPAGM homology eukaryotic orthologues. Amino acids conserved proteins highlighted dark grey. Sequences protozoa (T. brucei, T. cruzi L. major), yeasts (S. cerevisiae Candida albicans) mammals (Homo
sapiens PMM1) used alignments.  Sequences eukaryotic PMM family. conserved motifs indicated black boxes, arrow points Asp
residue phosphorylated reaction.
B. PAGM sequence alignment. Conserved motifs D-PHM family indicated black boxes, asterisks indicate invariant
residues arrow points P-Ser residue.


                                                                Â© 2012 Blackwell Publishing  Molecular Microbiology, 85, 513â€“534
                                                                                     PMM, PAGM phosphoglucomutase activity T. brucei 517

                                                                                     Fig. 3. TbPMM converts Man-1-P                                                                                      Man-6-P. Recombinant TbPMM                                                                                      incubated Man-1-P                                                                                      Glc-1,6-biphosphate cofactor products
                                                                                     reaction analysed                                                                                      HPAEC-PAD. peak corresponding                                                                                      Man-6-P observed presence                                                                                      recombinant enzyme (B),                                                                                      absence  . C. Kinetic analysis TbPMM
                                                                                     apparent Km Man-1-P                                                                                      327 â«¾ 66 mM maximum velocity                                                                                      2.6 â«¾ 0.4 nmol min-1 milligram protein
                                                                                     (Table 1).




T. brucei strain 427, sequenced (EMBL nucleotide                   (Fig. 3B), Man-6-P detected sequence database accession number FR851306                    TbPMM absent (Fig. 3A). used FR851307) cloned expression vector contain-            TbPMM convert GlcNAc-1-P ing N-terminal His6-tags expressed E. coli.           GlcNAc-6-P, case (Fig. S3A). Nickel column purification, TbPMM protein              procedure used determine kinetic
purified size exclusion chromatography (Fig. S1)            properties enzyme Man-1-P (Fig. 3C). Different tag removed incubation TEV protease            concentrations Glc-1,6-biP tested selecting
resulting band 27.9 kDa SDS-PAGE (Fig. S1).             optimal concentration 1 mM. apparent Km, Vmax TbPAGM, tag cleaved PreScission               catalytic efficiency recombinant TbPMM using
proteaseâ„¢ untagged protein purified            Man-1-P substrate shown Table 1. size exclusion chromatography (Fig. S2). molecu-            possible saturate reaction, TbPMM activity
lar masses identities tagged untagged               showed inhibition highest Man-1-P concentrations
recombinant proteins verified MALDI-TOF             (Fig. 3C). Consequently, equation high-substrate
LC-MS/MS peptide mass fingerprinting respectively (data            inhibition used calculate kinetic parameters shown). recombinant enzymes                 reaction. pH dependence TbPMM PMM activity
active tag, untagged recom-           analysed pH range 4.0 10.0. enzyme
binant enzymes used activity assays            showed activity pH 5.0 8.0 optimum
case TbPMM, crystallization trials.                         pH 6.5 (data shown).
   high-pH anion exchange chromatography pulsed                HPAEC-PAD used amperometric detection (HPAEC-PAD) used                 activity recombinant TbPAGM GlcNAc-1-P assay activity recombinant TbPMM,                 GlcNAc-6-P, Glc-1,6-biP cofactor (Fig. 4B).
described Experimental procedures. clear            TbPAGM able convert Man-1-P Man-6-P TbPMM convert Man-1-P Man-6-P presence               vitro (Fig. S3B);  discussed later, activity glucose-1,6-biphosphate (Glc-1,6-biP) cofactor             able compensate knockdown TbPMM

Â© 2012 Blackwell Publishing  Molecular Microbiology, 85, 513â€“534
 518 G. Bandini et al. äŠ?

Table 1. Comparison kinetic properties recombinant TbPMM TbPAGM different sugar phosphates substrates.

                                   TbPMM                                                             TbPAGM

                                                                                                                                IC50 (mM                  Km             vmax                Kcat/Km        Km             vmax                Kcat/Km
Substrate        (mM)           (nmol min-1)        (M-1 s-1)      (mM)           (nmol min-1)        (M-1 s-1)     GlcNAc-6-P         GlcNAc-1-P

Man-1-P          327 â«¾ 66b        2.6 â«¾ 0.4         3.7 Â¥ 105
Glc-6-P           96 â«¾ 8c       0.331 â«¾ 0.008       5.7 Â¥ 104      107 â«¾ 17b       0.23 â«¾ 0.03        9.4 Â¥ 104     8.3 â«¾ 0.4          6.3 â«¾ 2.6
GlcNAc-6-P                                                          14 â«¾ 6c       0.051 â«¾ 0.006       1.6 Â¥ 105
  IC50 GlcNAc phosphates competitive inhibitors formation Glc-1-P.
b. kinetic constants calculated using equation high-substrate inhibition based best-fit non-linear lines.
c. kinetic constants calculated Michaelisâ€“Menten equation.


 vivo. kinetic parameters conversion                       10.0 pH range. enzyme showed broad optimum
GlcNAc-6-P GlcNAc-1-P TbPAGM determined                          pH 7.2 9.1 (data shown).
using TbUAP pyrophosphorylase coupled assay colorimetric detection (Stokes et al., 2008)                                                                             TbPMM TbPAGM convert Glc-6-P
96 plate format, described Experimental
                                                                            Glc-1-P
procedures. TbPAGM enzyme followed classic
Michaelisâ€“Menten kinetics (Fig. 4C) apparent Km,                    ability TbPMM TbPAGM catalyse reac-
Vmax catalytic efficiency recombinant TbPMM                     tion assessed incubating recombinant
using GlcNAc-6-P substrate shown Table 1.                     enzyme presence Glc-1-P. cases pH dependence TbPAGM studied 4.0                       formation Glc-6-P detected HPAEC-PAD


                                                                                                  Fig. 4. TbPAGM interconverts GlcNAc
                                                                                                  phosphates. Recombinant TbPAGM                                                                                                   incubated GlcNAc-1-P                                                                                                   Glc-1,6-biphosphate cofactor,                                                                                                   indicated, products reaction
                                                                                                  analysed HPAEC-PAD. peak
                                                                                                  corresponding GlcNAc-6-P observed                                                                                                   presence recombinant enzyme                                                                                                   cofactor (B), cofactor                                                                                                   removed reaction  . C. Kinetic
                                                                                                  analysis TbPMM apparent Km
                                                                                                  GlcNAc-6-P 14 â«¾ 6 mM maximum
                                                                                                  velocity 0.051 â«¾ 0.006 nmol min-1                                                                                                   milligram protein (Table 1).




                                                                     Â© 2012 Blackwell Publishing  Molecular Microbiology, 85, 513â€“534
                                                                                      PMM, PAGM phosphoglucomutase activity T. brucei 519

(Fig. S4). Glc-1-P substrate UGP,             crystallization LmPMM (Kedzierski et al., 2006). able set assay conversion Glc-6-P         cases, TbPMM behaved monomer oligomers Glc-1-P coupling TbPMM TbPAGM TbUGP                 observed (Fig. S5). noted produce UDP-Glc presence UTP (MariÃ±o et al.,          TbPMM analysed size exclusion chromatography
2010).  single peak eluted UDP-Glc             high salt purification process, retention detected HPAEC-UV A260,               time consistent apparent molecular weight TbPMM TbPAGM coupled recombinant                (MW) homodimer (data shown). TbUGP (Fig. 5B D). Removal PHM              dimeric state TbPMM observed high
reaction resulted loss UDP-Glc peak (Fig. 5A         concentrations salt, physiological condi- C).                                                            tions, concluded biological assembly TbPMM    kinetic parameters conversion Glc-6-P         monomer.
Glc-1-P TbPMM TbPAGM determined                      Comparison TbPMM crystal structure discontinuous coupled assay TbUGP colorimet-             monomers L. mexicana human enzymes
ric detection. assay measures pyrophosphate               showed overall structure conserved
(PPi) product Glc-1-P + UTP â†’ UDP-Glc + PPi                 (Fig. 7A), residues forming active site
coupling reaction conversion PPi inorganic           (Fig. 7B). previously described, residues involved phosphate detection molybdate reagent               catalysis located core domain (aa 5â€“82 Experimental procedures). kinetic values TbPMM              187â€“246): D9 (Motif  corresponds Asp TbPAGM listed Table 1. Interestingly, TbPAGM            phosphorylated reaction, S45 (motif II) K187
activity inhibited highest concentrations Glc-       (Motif III) involved binding phosphate, 6-P saturation observed kinetic         D9, D11 (Motif , D206 D214 (Motif IV) ordinate analysis (Fig. 5F). inhibition detected        Mg2+ ion (Fig. 7B C) (Allen Dunaway-Mariano, case TbPMM (Fig. 5E).                                       2004; Quental et al., 2010). cap domain contributes
   affinity TbPAGM GlcNAc-6-P              residues involved substrate recognition (E119, R121,
10-fold higher Glc-6-P, investigated           M124, N126, R132, R139, S177), active site GlcNAc-6-P act competitive inhibitor             located groove interface core cap
formation Glc-1-P. confirmed running            domains (Fig. 7A) (Kedzierski et al., 2006; Silvaggi et al.,
assay 100 mM Glc-6-P  e. apparent Km                2006). electron density map solved structure
TbPAGM Glc-6-P) presence increasing              revealed sulphate ion monomerâ€™s active site, centrations GlcNAc-6-P, IC50                    approximately position 1-phosphate
8.3 â«¾ 0.4 mM (Fig. 6A). GlcNAc-1-P inhibited              moiety Glc-1,6-biP cofactor (Kedzier-
conversion Glc-6-P Glc-1-P comparable IC50         ski et al., 2006). ion ordinates directly R139
6.3 â«¾ 2.6 mM (Fig. 6B).                                            R132, linking waters S177 R121
                                                                   (Fig. 7C). Overlaying structure 2i55, LmPMM
                                                                   structure Glc-1,6-biP bound, phospho-sugar fits
Determination analysis TbPMM structure
                                                                   quite closed pocket TbPMM. Fig. 7B, crystal structure length TbPMM solved          strict conservation pocket. (PDB accession number 3F9R) molecular replacement               LmPMM structure, D10, D207 D215 engaged using modified form L. mexicana PMM (LmPMM;               ordinating Mg2+ ion D10 supposed form PDB accession number 2i54). crystallographic               phosphoprotein intermediate TbPMM structure,
model refinement data TbPMM structure                  Asp residues conserved (D9, D11, D206 reported Table 2. polypeptide units seen           D214), Mg2+ ion electron crystals asymmetric unit, chains B.              density. additional magnesium added protein
symmetry mates extended, monomer formed                prior crystallization, density magnesium
dimer symmetry mates, e. : B : B.           ion distal enzyme dimers mimicked dimerization mode seen                magnesium-binding site PMMs structures human LmPMM structures (Fig. S6).                         (2i55, 2fue).
   oligomeric state TbPMM studied analytical            quaternary structure TbPMM main dif-
ultracentrifugation (AUC) size exclusion chromatogra-          ference enzyme described
phy. Recombinant TbPMM analysed AUC                  eukaryotic PMMs, homodimers (Kepes different buffers: containing sodium chloride physi-        Schekman, 1988; Kedzierski et al., 2006; Silvaggi et al.,
ological concentrations (10 mM HEPES pH 7.5, 150 mM                2006), analysed residues hypothetical
NaCl) salt (10 mM Tris-HCl pH 7.5,             dimer interface. Analysis using PISA-EBI identified 12
1 mM DTT). buffer used                residues potentially involved H-bonding salt bridge

Â© 2012 Blackwell Publishing  Molecular Microbiology, 85, 513â€“534
 520 G. Bandini et al. äŠ?

                                                               Fig. 5. TbPMM TbPAGM
                                                               convert Glc-6-P Glc-1-P.
                                                               TbPMM TbPAGM used
                                                               coupled assay TbUGP
                                                               presence Glc-6-P                                                                UTP, indicated. products
                                                               reactions analysed                                                                HPAEC UV detection.
                                                               Formation UDP-Glc (indicative
                                                               conversion Glc-6-P                                                                Glc-1-P) observed                                                                TbPMM (B) TbPAGM (D).                                                                sugar nucleotide peak                                                                detected absence                                                                phospho-sugar mutase                                                                 C). kinetic analyses                                                                recombinant TbPMM (E)                                                                TbPAGM (F) performed
                                                               using TbUGP-coupled assay
                                                               colorimetric detection.                                                                results Table 1.




                          Â© 2012 Blackwell Publishing  Molecular Microbiology, 85, 513â€“534
                                                                                           PMM, PAGM phosphoglucomutase activity T. brucei 521

                                                                       consistent interface residues having role                                                                        multimer formation.


                                                                       Subcellular localization TbPMM TbPAGM                                                                        bloodstream form T. brucei
                                                                       Subcellular localization enzymes studied
                                                                       immunofluorescence microscopy. Paraformaldehyde-
                                                                       fixed wild type bloodstream form T. brucei cells incu-
                                                                       bated polyclonal mouse anti-TbPMM (Fig. 8A) anti-
                                                                       TbPAGM (Fig. 8B) combined rabbit polyclonal
                                                                       anti-GAPDH, glycosomal marker (images d)                                                                        rabbit anti-enolase, cytosolic marker (images e h).
                                                                       Cells washed incubated mix Alexafluor
                                                                       488 anti-mouse IgG (green) Alexafluor 594 anti-rabbit
                                                                       IgG (red). Anti-TbPMM showed punctate staining pattern
                                                                       substantial colocalization anti-GAPDH (Fig. 8A,
                                                                       images d), absence colocalization                                                                        anti-enolase (Fig. 8A, images e h), indicating                                                                        TbPMM glycosomal enzyme. hand,
                                                                       TbPAGM showed punctate diffuse staining,                                                                        agreement partial colocalization GAPDH
                                                                       (Fig. 8B, images d) enolase (Fig. 8B, images
                                                                       e h), respectively, indicating TbPAGM located                                                                        glycosomes cytosol.
                                                                          subcellular localization TbPMM TbPAGM
                                                                       studied digitonin latency, described previ-
                                                                       ously (Galland et al., 2007), using Western blotting                                                                        proteins released escalating digitonin concentrations
                                                                       (Fig. 8C). TbPMM poorly released lower
                                                                       concentrations digitonin increased gradually                                                                        increasing digitonin concentration, reaching maximum


Fig. 6. GlcNAc-6-P GlcNAc-1-P inhibit formation         Table 2. Data collection crystallographic refinement.
UDP-Glc vitro. TbPAGM used source PGM
activity step UDP-Glc formation, biosynthesis   Data collection sugar nucleotide inhibited presence       Space group                                                P21212
GlcNAc-6-P   GlcNAc-1-P (B).  sugar phosphates         Cell dimensions
compete Glc-6-P binding TbPAGM IC50 values           (Ã…)                                                    105.93
8.3 â«¾ 0.4 mM 6.3 â«¾ 2.6 mM respectively (Table 1).                    b (Ã…)                                                    46.99
                                                                         c (Ã…)                                                    94.49
                                                                       Wavelength                                                 1.5418
                                                                       Resolution                                                 50â€“1.8 (1.86)
interactions (N91, K99, R103, A106, D107, D109, P111,                  Unique reflections                                         44 877
R114, T116, V118, Y120 N133) 14 residues                       Rmerge                                                     0.122 (0.862)
involved hydrophobic interactions                   Mean s                                                 17.83 (1.40)
                                                                       Completeness ( )                                           99.9 (99.3)
TbPMM structure. residues conserved                  Redundancy                                                 6.2 (4.4) LmPMM interface, exception amino                 PDB code                                                   3F9R
acids. (I94 Y120) partially involved             Refinement
                                                                       Resolution                                                 50â€“1.85 hydrophobic interactions correspond                      Number reflections                                      41 076
LmPMM residues V95 F121. substitution                    Test set                                                   2074
occurs R103, LmPMM H104 (Fig. 7D). Inter-               Rwork/Rfree                                                0.202/0.266
                                                                       RMS deviations
estingly, PISA-EBI macromolecular analysis tool finds                Bond lengths (Ã…)                                         0.016 low complexation significance score (CSS) TbPMM                    Bond angles (Â°)                                          1.471
(0.017) suggesting monomeric quaternary                      Average B value (Ã…2)                                       31.63

structure. comparison, CSS LmPMM 0.249,

Â© 2012 Blackwell Publishing  Molecular Microbiology, 85, 513â€“534
 522 G. Bandini et al. äŠ?




Fig. 7. High-resolution crystal structure TbPMM.  Comparison TbPMM structure (green) monomers LmPMM (yellow) H. sapiens PMM1 (magenta).
B. Active sites TbPMM (blue) Glc-1,6-biP cofactor modelled compared LmPMM (grey). Asp residues involved phosphoprotein intermediate (D9) Mg2+ ordination (D11, D206 D214) conserved, S45 R187, involved phosphate moiety recognition. S45 shown possible conformations.
C. sulphate ion position phosphate group substrate expected. ion ordinated R139 R132 directly R121 S177 water molecules. TbPMM structure shown blue LmPMM grey.
D. Comparison surface interfaces TbPMM (green) LmPMM (beige). mutated residues labelled.


 0.1 mg digitonin/mg protein. pattern similar             cipitated single band correct apparent MW aldolase (aldo), lumenal glycosome resident                2 Â¥ 108 cell equivalents trypanosome detergent lysate
enzyme, indicating TbPMM glycosomal                       (Fig. 8D, lane 2).
enzyme. Lower MW bands observed higher                         Digitonin latency used study cellular
centrations digitonin 0.1  Triton X-100 (Fig. 8C,              location TbPAGM. Unlike TbPMM, TbPAGM sub-
lanes 7 8 respectively) probably proteolytic              stantially released low concentrations digitonin, degradation TbPMM, non-specificity                  pattern similar enolase (eno), cytosolic protein. affinity-purified antibody specifically immunopre-               release TbPAGM increased gradually

                                                                  Â© 2012 Blackwell Publishing  Molecular Microbiology, 85, 513â€“534
                                                                                      PMM, PAGM phosphoglucomutase activity T. brucei 523

                                                                                      Fig. 8. Subcellular localization TbPMM
                                                                                      TbPAGM. Immunofluorescence
                                                                                      microscopy performed                                                                                       paraformaldehyde-fixed bloodstream form
                                                                                      T. brucei cells stained mouse
                                                                                      anti-TbPMM   mouse anti-TbPAGM (B)
                                                                                      sera combined glycosomal marker rabbit
                                                                                      anti-GAPDH (images d) cytosolic
                                                                                      marker rabbit anti-enolase (images e h).
                                                                                      Merged images shown images c g
                                                                                      corresponding phase contrast images                                                                                       shown images d h. scale bar (10 mm)
                                                                                      shown  image e. subcellular
                                                                                      localization TbPMM TbPAGM                                                                                       studied digitonin latency, e. release                                                                                       specific proteins, judged Western
                                                                                      blotting antibodies TbPMM                                                                                       TbPAGM, glycosomal marker aldolase
                                                                                      (aldo) cytosolic marker enolase (eno),
                                                                                      increasing concentrations digitonin
                                                                                      (C). TbPMM blot, arrow
                                                                                      indicates intact TbPMM                                                                                       arrow indicates TbPMM proteolytic products.
                                                                                      specificity TbPMM antibody (D)                                                                                       tested Western blotting                                                                                       immunoprecipitate using antibody
                                                                                      2 Â¥ 108 bloodstream form cells (lane 2)
                                                                                      25 ng recombinant
                                                                                      TbPMM (lane 1). MW markers shown
                                                                                      left.



 increase digitonin concentration (Fig. 8A,             expressing tetracycline inducible double-stranded RNA
compare lanes 2 7) indicating PAGM dual             (dsRNA) targeting TbPMM TbPAGM respectively.
localization cell, glycosomal cytosolic.                  Induction dsRNA targeting TbPMM resulted                                                                    68 â«¾ 18  knockdown TbPMM mRNA 48 h                                                                     judged qRT-PCR replicates) reduction
RNAi knockdown TbPMM TbPAGM                                                                    growth rate led cell death 72 h, demonstrat-
effects sugar nucleotide metabolism bloodstream
                                                                   ing essentiality TbPMM (Fig. 9A). Phenotypic
form T. brucei
                                                                   analyses knockdown cell line carried contributions TbPMM TbPAGM biosyn-               24 h 48 h post dsRNA induction. expression thesis UDP-Glc UDP-Galp studied RNAi.               TbPAGM protein evaluated Western blot case
Fragments 464 497 bp TbPMM TbPAGM                    enzyme, interconvert Man-1-P Man-
ORFs, respectively, cloned p2T7TABlue            6-P, upregulated induced TbPMM RNAi
resulting constructs used generate cell lines          cells compensate loss TbPMM, 
Â© 2012 Blackwell Publishing  Molecular Microbiology, 85, 513â€“534
 524 G. Bandini et al. äŠ?




Fig. 9. Characterization TbPMM RNAi effects.  Growth curves TbPMM RNAi cell line induced tetracycline (solid line) induced (dashed line).
B. Western blot total cell lysates induced (lanes 1 3) induced (lanes 2 4) TbPMM RNAi cells stained Ponceau
(lanes 1 2) antibodies TbPAGM (lanes 3 4).
C. levels sugar nucleotide determined LC-MS/MS wild type cells (white), induced TbPMM RNAi cell line (striped) TbPMM RNAi cell line induced 24 h (grey) 48 h (black). P-values (P) determined t-test; double asterisk indicates P < 0.005.
D. extent N-glycosylation sVSG221 assessed anti-sVSG221 Western blot cell lysates wild type (WT) cells
(lane 1) TbPMM RNAi cells induced (+) induced (-) tetracycline 1 day 2 days, indicated. lower band lanes 2 4, marked spot, consistent sVSG221 lacking N-glycans.




                                                                   Â© 2012 Blackwell Publishing  Molecular Microbiology, 85, 513â€“534
                                                                                       PMM, PAGM phosphoglucomutase activity T. brucei 525
 case (Fig. 9B). Sugar nucleotides extracted           enzymes mutually redundant induced induced TbPAGM TbPMM RNAi                  conversion Glc-6-P Glc-1-P.  reduc-
cell lines wild type cells, separated HPLC         tion GDP-sugars levels observed knock-
quantified electrospray ionization tandem mass spec-            TbPMM expression, likewise reduction trometry, previously described (Turnock Ferguson,           UDP-GlcNAc levels observed case TbPAGM
2007). TbPMM RNAi cell line GDP-Man levels              knockdown, significant reduction UDP-Glc UDP- reduced induction, expected.  GDP-               Gal observed cell line.
Man reduced 55  50  (P < 0.005) wild
type levels 24 48 h dsRNA induction respec-
tively, downstream GDP-Man metabolite, GDP-
                                                                   Discussion
Fuc, reduced 40  (P = 0.001) wild type levels            genes encoding putative PMM PAGM 48 h (Fig. 9C).  condi-           enzymes T. brucei genome, bio-
tions UDP-sugar levels similar         chemically confirmed  gene encoding putative
wild type induced cells (Fig. 9C). data           PGM, enzyme responsible synthesis Glc-1-P  unlike GDP-Man GDP-Fuc, synthesis                 Glc-6-P, (Berriman et al., 2005;
UDP-Glc UDP-Gal critically dependent             Turnock Ferguson, 2007). absence T. brucei
expression TbPMM. evidence mannose star-             PGM gene particularly perplexing.  vation induced TbPMM RNAi cell line obtained            T. cruzi Leishmania easily identifiable PGM Western blotting anti-VSG antibodies (Fig. 9D).            genes T. cruzi PGM enzyme biochemi-  evident 24 h clear           cally characterized (Penha et al., 2005; 2009) 
48 h, TbPMM knockdown leads N-glycosylation               second, known route identified sVSG221, previously described conditional            T. brucei metabolite UDP-Glc (Turnock Ferguson,
null mutant T. brucei GDP-Man pyrophosphorylase                 2007) UGP (MariÃ±o et al., 2010). UGP uses
(Denton et al., 2010).                                             Glc-1-P UTP substrates, known
   induction dsRNA targeting TbPAGM caused                  route Glc-1-P Glc-6-P PGM activity, follows slight reduction cell growth (Fig. 10A),            T. brucei possess enzyme PGM activity. level TbPAGM protein 2 3 days              Furthermore, flux UDP-Glc, induction reduced 15  wild type levels             Glc-1-P, known considerable blood-
30  induced levels respectively (Fig. 10B).               stream form procyclic form T. brucei (Turnock compensatory difference RNA levels TbPMM                Ferguson, 2007). UDP-Glc obligate observed TbPAGM RNAi cell line,                  precursor UDP-Gal (Roper et al., 2002; 2005; Shaw induced induced 2 3 days (data shown).            et al., 2003; Urbaniak et al., 2006b)  turn, used 48 h induction, sugar nucleotide levels        synthesize galactose-containing glycoproteins TbPAGM RNAi cell line agreed reasonably                  parasite, including highly abundant VSG coat gly- induced wild type cells (Fig. 10C).                coprotein procyclins bloodstream pro-  72 h induction, UDP-GlcNAc levels            cyclic forms parasite respectively. biochemical 25  30  (P < 0.05) induced wild                 characterization TbPMM TbPAGM described type levels respectively, sugar nucleotide         paper resolves metabolic paradox, levels remained comparable induced                  enzymes capable converting Glc-6-P Glc-1-P, cells (Fig. 10C). Despite significant knockdown             interconverting definitive mannose- TbPAGM protein levels, evidence GlcNAc starvation,             N-acetylglucosamine-phosphate substrates. Certain e. N-glycosylation sVSG221 previously                PMMs PAGMs shown similarly pro-
described conditional null mutants T. brucei            miscuous organisms (Fernandez-Sorensen UDP-GlcNAc pyrophosphorylase glucosamine-6-P                   Carlson, 1971; Boles et al., 1994; Hofmann et al., 1994;
N-acetyltransferase (Stokes et al., 2008; MariÃ±o et al.,           Oesterhelt et al., 1996; Pirard et al., 1999; Kato et al.,
2011), barely detectable (Fig. 10D). noted              2005; Qian et al., 2007), known example
previously growth defects occur blood-              PGM activity completely replaced PMM stream form T. brucei UDP-GlcNAc levels fall           PAGM. Analysis synteny trypanosomatid
20  wild type levels (Stokes et al., 2008)         genomes (Fig. S7; El-Sayed et al., 2005b) suggests appear RNAi knockdown TbPAGM achieved                  T. brucei deleted PGM gene point deep significantly affect protein            evolution, presumably PMM PAGM
glycosylation cell growth.                                     attained sufficient catalytic flexibility support Glc-6-P
   conclusion, analysis sugar nucleotide             Glc-1-P conversion  opposite situation levels TbPMM TbPAGM RNAi cell lines suggests                recently reported protozoan parasite, Giardia

Â© 2012 Blackwell Publishing  Molecular Microbiology, 85, 513â€“534
 526 G. Bandini et al. äŠ?




Fig. 10. Characterization TbPAGM RNAi effects.  Growth curves TbPAGM RNAi cell line induced tetracycline (solid line) induced (dashed line).
B. Western blot TbPAGM protein total lysates wild type cells (lane 5) TbPAGM RNAi cells induced (lanes 2 4) induced
(lanes 1 3) tetracycline day 2 (lanes 1 2) 3 (lanes 3 4). Licor quantitative data, normalized aldolase (aldo)
signal, plotted blot.
C. levels sugar nucleotide determined LC-MS/MS wild type cells (white), induced TbPAGM RNAi cell line (stippled) TbPMM RNAi cell line induced 48 h (squared) 72 h (bold horizontal stripes). P-values (P) determined t-test; asterisk indicates P < 0.05.
D. extent N-glycosylation sVSG221 assessed anti-sVSG221 Western blot cell lysates wild type (WT) cells
(lane 5) TbPAGM RNAi cells induced (+) induced (-) tetracycline 2 days 3 days, indicated. lower band lanes 1 3, marked spot, consistent sVSG221 lacking N-glycans.




                                                                     Â© 2012 Blackwell Publishing  Molecular Microbiology, 85, 513â€“534
                                                                                      PMM, PAGM phosphoglucomutase activity T. brucei 527

lamblia. organism obvious PMM gene                 Man-6-P,  reversible phosphomannose
instead evolved PGMs: canonical glucose                  isomerase reaction, lead fructose-6-phosphate
phosphate-specific PGM divergent able                 enter glycolytic pathway. ability convert mannose-phosphates (Mitra et al., 2010).                   divert significant portion carbon metabolism    PGM activities TbPMM TbPAGM appear                GDP-sugar nucleotides fuel glycoprotein synthesis mutually redundant, RNAi knockdown            rapidly dividing trypanosomes, automatically shunt turn significant effect UDP-Glc UDP-Gal           glycolysis glycoprotein synthesis levels. despite fact Western blot unpub-      repressed non-dividing cells, suggests mechanism
lished proteomic data strongly suggest TbPAGM              help trypanosomes manage transformations abundant TbPMM.  interesting           non-dividing metacyclic trypomastigotes TbPAGM, interconvert mannose-                  rapidly dividing slender trypomastigotes slender
phosphates, substitute TbPMM                   non-dividing stumpy trypomastigotes.  RNAi knockdown TbPMM affects protein gly-               organisms, PMM PAGM activities cosylation suppresses parasite growth. consis-         located cytosol.  bloodstream form
tent previous studies using conditional null mutants          T. brucei, TbPMM localizes glycosomes downstream enzymes pathway                TbPAGM localizes glycosomes cytosol.
GDP-Man metabolite GDP-Fuc essential           glycosomes T. brucei related trypanosomatids
(Turnock et al., 2007; Denton et al., 2010). contrast,      belong, glyoxysomes plants 
RNAi knockdown TbPAGM described insuffi-               oxisomes eukaryotes, microbody family cient significantly affect protein glycosylation sup-        organelles. compared microbodies,
press growth. despite fact conditional        trypanosomatid glycosomes unique essential
null mutants glucosamine-6-P N-acetyltransferase            role carbohydrate metabolism, e. seven steps
UDP-GlcNAc pyrophosphorylase                    glycolysis, gluconeogenesis, glycerol metabolism stream enzymes leading UDP-GlcNAc clearly                   pentose-phosphate pathway (Michels et al., 2006;
essential (Stokes et al., 2008; MariÃ±o et al., 2011).          Haanstra et al., 2008). Glycosomal proteins typically
notion phospho-sugar mutase(s)  addition         targeted organelles Peroxisomal Targeting TbPMM TbPAGM) exist T. brucei           Sequences (PTS), located C-terminus
perform PGM function excluded searches               (PTS-1) N-terminus (PTS-2) protein. Internal target-
updated trypanosomatid genomes TriTrypDB (Aslett                ing sequences proposed tar-
et al., 2010) protein family (PFAM) domains         geting mechanism, T. cruzi PGM T. brucei
relevant PMM, PAGM PGM activities (PF03332,                 triosephosphate isomerase (Penha et al., 2009; Galland
PF02878, PF02879, PF02880 PF00408).                      et al., 2010) proteins reach organelles searches returned PMM PAGM genes                  â€˜piggybackingâ€™ glycosome-targeted proteins
African trypanosomes, returned PMM,                   (Titorenko et al., 2002). canonical trypanosome PTS
PAGM PGM genes T. cruzi Leishmania.                sequences apparent TbPAGM TbPMM
   TbPMM enzyme unusual features                  T. cruzi L. major PMM orthologues compared eukaryotic PMMs.  apparent             contain PTS-1 sequences (Opperdoes Szikora,
Km Man-1-P relatively high (327 â«¾ 66 mM) com-            2006)], likely use piggybacking
parison values reported Arabidopsis thaliana            mechanism unidentified internal targeting
(29.7 mM) (Qian et al., 2007), Galderia sulphuraria                sequence. inefficient import TbPAGM glyco-
(50 mM) (Oesterhelt et al., 1996), human PMM1                  somes explain partial localization enzyme
(3.2 mM) PMM2 (18 mM) (Pirard et al., 1997; 1999).             cytosol bloodstream form T. brucei. case,
Second, unlike aforementioned enzymes, TbPMM                TbPMM TbPAGM join growing list enzymes
inhibited high levels Man-1-P.  PMMs,          novo sugar nucleotide biosynthesis including L. mexicana (Kedzierski et al., 2006),       localized glycosomes. include hexokinase
typically homodimers, TbPMM appears monomer                phosphoglucose isomerase (Visser Opperdoes, physiological conditions. properties             1980), glucosamine-6-P N-acetyltransferase (MariÃ±o
T. brucei GDP-Man pyrophosphorylase, shows sig-              et al., 2011), TbUAP (Stokes et al., 2008), TbUGP (MariÃ±o
nificant product inhibition (Denton et al., 2010),             et al., 2010), GalE (Roper et al., 2005), phosphomannose
TbPMM, shows product inhibition Man-6-P            isomerase (Colasante et al., 2006) GDP-mannose
Man-1-P direction, assist coupling GDP-sugar            4,6-dehydratase (Turnock et al., 2007). possible synthesis glycoprotein synthesis.  reduction          sugar nucleotide biosynthesis machinery
glycoprotein precursor synthesis reduce                  localized glycosome T. brucei rate
demand GDP-Man lead accumulation                  synthesis metabolites controlled, 
Â© 2012 Blackwell Publishing  Molecular Microbiology, 85, 513â€“534
 528 G. Bandini et al. äŠ?

degree, â€˜compartmentalizationâ€™. mechanism                thiogalactopyranoside (IPTG). harvesting, cells proposed alternative allosteric regu-            resuspended 50 mM Tris-HCl pH 7.3, 150 mM NaCl,
lation glycolysis T. brucei (Haanstra et al., 2008).            100 mM imidazole, 1 mM DTT, 1 mg ml-1 lysozyme Com-
                                                                       plete Protease Inhibitor Cocktail Tablets (Roche)    summary, expressed characterized                                                                        lysed using French press. cell lysate cleared PMM PAGM enzymes T. brucei determined                       centrifugation (17 000 g, 4Â°C, 30 min), filtered subcellular locations high-resolution crystal            0.2 mm cellulose acetate membrane (Whatman) loaded
structure TbPMM.  analysing substrate              5 ml Ni2+ HiTrapâ„¢ Chelating HP column (GE
specificities, provided solution appar-              Healthcare). Fractions collected checked SDS-
ently paradoxical absence PGM gene T. brucei                PAGE. TbPMM containing fractions pooled demonstrating TbPMM TbPAGM inter-                    digested 0.1 mg PreScissionâ„¢ protease GST-tagged
                                                                        kind gift Daan van Aalten, University Dundee) 
convert Glc-6-P Glc-1-P. Selective knockdown                                                                        night 4Â°C. PreScissionâ„¢ protease removed TbPMM TbPAGM inducible RNAi analysis                     incubating sample 2 h 4Â°C 50 ml Glutathione
sugar nucleotide levels suggests mutually                Sepharoseâ„¢ 4 Fast Flow (GE Healthcare) slurry redundant particular function. clear          separating beads centrifugation. fraction routes key sugar-1-phosphates (Man-1-P,                   untagged TbPMM, present supernatant, used GlcNAc-1-P Glc-1-P) key sugar                   mouse rabbit immunization. remaining recombinant
nucleotides (GDP-Man, GDP-Fuc, UDP-GlcNAc, UDP-                        protein used coupling CNBr Sepharose beads.
Glc UDP-Gal) dependent just enzymes:
TbPMM TbPAGM, thera-                      TbPMM protein expression purification activity
peutic potential.                                                      assays crystallization trials

                                                                       TbPMM ORF amplified described cloned
                                                                       pET15-MHL vector (GenBank ID EF456738) Experimental procedures                                                transformed E. coli BL21-(DE3)-V2R-pRARE2. single
DNA isolation manipulation                                         colony inoculated 100 ml LB medium contain-
                                                                       ing ampicillin/chloramphenicol (100 mg ml-1 34 mg ml-1
Plasmid DNA purified Escherichia coli (DH5a) using            respectively) inside 250 ml baffled flask incubated Qiagen Miniprep Maxiprep kit appropriate. Gel                shaking 250 r.p.m. overnight 37Â°C. culture extraction performed using QIAquick kits. Custom oligo-            transferred 1.0 l TB antibiotic formula-
nucleotides obtained University Dundee                tion pre-added. culture allowed grow LEX
oligonucleotide facility. T. brucei genomic DNA isolated           (Harbinger Biotechnology Engineering) 1 Â¥ 108 bloodstream form cells using DNAzol (Helena               OD600 5â€“6, cooled 15Â°C induced 0.5 mM IPTG
Biosciences). T. brucei cell cultures mycoplasma-free.         overnight temperature. culture harvested     plasmids verified sequencing (DNA Sequenc-             centrifugation. resulting pellets resuspended ing Service, College Life Sciences, University Dundee;           approximately 40 ml l-1 cell culture Binding Buffer (50 mM
http://www.dnaseq uk). Recombinant proteins iden-              HEPES pH 7.5, 500 mM NaCl, 5 mM imidazole 5  glyc-
tified Proteomics Mass Spectrometry Facility,               erol) protease inhibitors (1 mM benzamidine 1 mM
College Life Sciences, University Dundee.                        phenylmethyl sulphonyl fluoride) added, stored -80Â°C.
    Protein sequence multiple alignments assembled                   day purification, pellets thawed
using ClustalW (Chenna et al., 2003) Jalview (Water-               overnight 4Â°C. pellet 1 l culture pre-
house et al., 2009).                                                   treated 0.5  CHAPS 500 units benzonase                                                                        40 min room temperature, subsequently sonicated.
                                                                       6 min sonication, cell lysate centrifuged using TbPMM expression purification                                  Beckman JA-25 rotor 24 000 r.p.m. 20 min 4Â°C. antibody production                                                    cleared lysate loaded 1.0â€“2.5 ml Ni-NTA (Qiagen)
                                                                       open column (pre-equilibrated Binding Buffer) TbPMM (Tb927.10.6440) ORF amplified PCR                     approximately 1.5â€“2.0 ml min-1. Ni-NTA column T. brucei genomic DNA Platinum Taq DNA poly-                 washed 150 ml Wash Buffer (50 mM HEPES
merase High Fidelity (Invitrogen) using forward reverse            pH 7.5, 500 mM NaCl, 30 mM imidazole 5  glycerol) primers containing NdeI XhoI restriction sites               2â€“2.5 ml min-1. protein eluted Elution
lined) respectively: 5â€²-GGAATTCCATATGAAAAGAGTTCTT                      Buffer (50 mM HEPES pH 7.5, 500 mM NaCl, 250 mM imi-
TTACTCTTTGAC-3â€² 5â€²-CCGCTCGAGTTACTTCATGG                            dazole 5  glycerol). eluted sample applied CAATTATTTTTTCC-3â€². NdeI XhoI restriction sites                 Sephadex S200 16/60 gel filtration column (GE Healthcare) used clone TbPMM ORF pET15b                         pre-equilibrated Gel filtration Buffer (10 mM HEPES,
(Novagen) modified PreScissionâ„¢ Protease (PP)                   pH 7.5, 500 mM NaCl) AKTA explorer (GE
cleavage site, generating following expression construct:          Healthcare). fractions corresponding eluted protein
pET15b-His6-PP-TbPMM. recombinant TbPMM                        peak pooled treated TEV protease
expressed E. coli BL21(DE3). cells grown              overnight cut tag. mixture loaded night 16Â°C induction 0.75 mM isopropyl b-D-1-            1.0 ml Ni-NTA open column cut protein 
                                                                 Â© 2012 Blackwell Publishing  Molecular Microbiology, 85, 513â€“534
                                                                                        PMM, PAGM phosphoglucomutase activity T. brucei 529

collected flow  identity purity       stopped addition equal volume 0.2 M NaOH,
evaluated mass spectroscopy SDS-PAGE gel.                raising pH 12. samples analysed High
sample concentrated using 15 ml Amicon Ultra             Pressure Anion Exchange Chromatography coupled centrifugal filter device (Millipore) 10 mg ml-1 stored   Pulse Amperometric Detector (HPAEC-PAD, Dionex) using 4Â°C.                                                                CarboPac PA1 column conditions adapted Zhou
                                                                    et al. (2002). kinetic analysis, concentration                                                                     Man-1-P reaction varied 10 1000 mM.
TbPAGM protein expression purification activity             concentration analysed triplicates. high-
assays antibody production                                      substrate inhibition equation (1) based non-linear fit                                                                     used calculate kinetic parameters reaction.
TbPAGM (Tb927.8.980) amplified PCR T. brucei
                                                                                                  Vmax
genomic DNA Platinum Taq DNA polymerase High Fidel-                                 v=                                                 (1)
                                                                                                  Km S
ity (Invitrogen) using forward reverse primers containing                                  1+    +
NdeI XhoI restriction sites (underlined) respectively:                                         S   Ki
5â€²-GGAATTCCATATGGTGCTGCAGGCT-3â€² 5â€²-CGCCT                           kinetic data fitted using GraFit5.
CGAGCTACGCTCCACCGCAGA-3â€². NdeI XhoI
restriction sites used clone TbPAGM ORF          Activity assays conversion Glc-6-P
pET15b (Novagen) modified PreScissionâ„¢ Protease
                                                                    Glc-1-P
(PP) cleavage site, generating following expression 
struct: pET15b-His6-PP-TbPAGM. recombinant TbPAGM               conversion Glc-1-P Glc-6-P recombinant TbPMM expressed E. coli BL21(DE3). Cultures grown          TbPAGM followed HPAEC-PAD. condi-
37Â°C, LB medium containing ampicillin, OD600           tions reaction buffer described approximately 0.5. IPTG added final concentration          Man-1-P Man-6-P conversion, 25 ng of 0.5 mM cultures grown overnight 16Â°C.            enzyme used substrate changed Glc-1-P. cell pellets obtained centrifugation resus-            conversion Glc-6-P Glc-1-P TbPMM pended 50 mM Tris-HCl pH 7.7, 200 mM NaCl, 50 mM                 TbPAGM analysed using coupled assay imidazole, presence DNase  EDTA-free Complete           TbUGP. formation final product (UDP-glucose)
Protease Inhibitor Cocktail Tablets (Roche) 1 mg ml-1           followed HPAEC (Dionex) using CarboPac
lysozyme. cells lysed using French press         PA1 column UV detector set 260 nm. Different
cell lysate cleared centrifugation (20 000 g, 4Â°C, 30 min)       amounts recombinant proteins (50â€“400 ng) incu-
filtered 0.2 mm cellulose acetate membrane                bated 15 min room temperature 100 ml reaction volume
(Whatman) loaded 5 ml Ni2+ HiTrapâ„¢ Chelating             containing 2 mM Bis-Tris propane pH 7.3, 10 mM MgCl2,
HP column (GE Healthcare). TbPAGM-containing frac-              1 mM glucose-1,6-biphosphate, 500 mM Glc-6-P, 1 mM DTT,
tions pooled digested 0.1 mg PreScissionâ„¢          0.1 mg ml-1 BSA, 500 mM UTP 1 mg rx-1 TbUGP (Buffer
protease GST-tagged described  cleaved                 CA). reaction stopped addition equal
protein purified gel filtration using Superdex     volume 0.2 M NaOH.
G-200 10/30 column (Amersham) eluted 50 mM Tris-                Kinetic parameters determined using colorimetric
HCl pH 7.7, 200 mM NaCl.                                            assay 96 plate format (Cellstar) described                                                                     Stokes et al. (2008). Briefly, 25 ng recombinant TbPMM                                                                     TbPAGM incubated 100 ml reaction volume 15 min
Analytical ultracentrifugation                                      room temperature buffer CA, containing 0.08 U rx-1
                                                                    pyrophosphatase (Sigma). concentration Glc-6-P Recombinant untagged TbPMM analysed sedi-
                                                                    varied 10 1000 mM. addition 100 ml mentation velocity Beckman Optima XL-1 Analytical
                                                                    Biomol Green (Biomol International) 20 min incubation,
Ultracentrifuge AN50-Ti rotor 4Â°C, 32 000 r.p.m.
                                                                    A620 measured SpectraMax 340PC (Molecular quaternary structure protein studied 0.25,
                                                                    Devices) plate reader. Triplicates run point. 0.5 0.75 mg ml-1 different buffers:   10 mM
                                                                    high-substrate inhibition equation used
HEPES pH 7.5, 150 mM NaCl, (ii) 10 mM Tris-HCl pH 7.5,
                                                                    fit kinetic data TbPAGM.
1 mM DTT. Absorbance data collected analysed
                                                                       IC50 GlcNAc-1-P GlcNAc-6-P measured using
using SEDFIT software (Schuck, 2004). TbPMM                                                                     colorimetric coupled assay. Briefly, 25 ng TbPAGM assumed globular protein amino acid compo-
                                                                    incubated conditions described  fixed
sition used determine density.
                                                                    concentration Glc-6-P 100 mM used,                                                                     GlcNAc-1-P GlcNAc-6-P concentration varied
                                                                    1 250 mM. detection carried Activity assay conversion Man-1-P Man-6-P
                                                                     assay activity, 10 ng recombinant untagged TbPMM incubated 100 ml reaction volume 20 min room          Activity assays conversion GlcNAc-6-P
temperature buffer D (2 mM Bis-Tris propane pH 7.3, 5 mM         GlcNAc-1-P
MgCl2, 1 mM glucose-1,6-biphosphate, 50 ng BSA 250 mM Man-1-P). TbPAGM, 100 ng enzyme incu-             conversion GlcNAc-1-P GlcNAc-6-P recombi-
bated buffer D 1 h 37Â°C. reaction            nant TbPAGM followed HPAEC-PAD. condi-

Â© 2012 Blackwell Publishing  Molecular Microbiology, 85, 513â€“534
 530 G. Bandini et al. äŠ?

tions reaction buffer (Buffer D)                    2001). eluted sugar nucleotides analysed mul-
described Man-1-P Man-6-P conversion,                  tiple reaction monitoring LC-MS/MS (Turnock Ferguson,
expect 25 ng enzyme used substrate              2007). P-values determined using Studentâ€™s t-test.
changed GlcNAc-1-P. TbPMM, 250 ng enzyme incubated Buffer D containing 800 mM GlcNAc-1-P 1 h 37Â°C analysis HPAEC-PAD.                                   Crystallization data collection
   conversion GlcNAc-6-P GlcNAc-1-P TbPAGM analysed using coupled assay TbUAP colo-                Crystals TbPMM obtained setting protein
rimetric detection 96 plate format (Cellstar)              sample obtained described hanging drop
described  Briefly, 25 ng recombinant TbPAGM               vapour diffusion experiment 20Â°C. successful crystal-
incubated buffer CA (2 mM Bis-Tris propane pH 7.3,                   lization conditions leading structure  2 M
10 mM MgCl2, 1 mM glucose-1,6-biphosphate, 1 mM DTT,                    (NH4)2SO4, 0.2 M NaCl, 0.1 M sodium cacodylate, pH 6.0.
0.1 mg ml-1 BSA, 500 mM UTP 1.5 mg rx-1 TbUAP).                        Crystals data collection transferred paratone-N
Kinetic parameters determined varying concen-               cryoprotectant, flash frozen liquid nitrogen data
tration GlcNAc-6-P 5 100 mM. Triplicates                 collected Rigaku FRE Superbright anode run point.                                                RAXIS-IV plate imager. complete data set collected,
                                                                        indexed scaled HKL2000 program (Otwi-
                                                                        nowski Minor, 1997).
Parasite culture

Bloodstream form T. brucei parasites (strain 427, variant               Structural determination model refinement
MITat1.2) expressing T7 polymerase tetracycline repres-
sor protein G418 selection (Wirtz et al., 1999)              structure TbPMM solved molecular replace-
grown HMI-9t medium 37Â°C 5  CO2. HMI-9T                 ment using program PHASER LmexPMM struc-
variant HMI-9 medium described Hirumi                     ture (2i54) modified chains replaced Hirumi (1994) thioglycerol used instead                     Tb sequence FFAS03 (Jaroszewski et al., 2005). b-mercaptoethanol (Greig et al., 2009).                                 model refined 1.85A data using initial round                                                                         ARP/WARP, followed iterative manual rebuilding COOT
                                                                        refinement REFMAC 5.5.0109 (ccp4 Suite, Murshu-
Generation RNAi constructs transformation                     dov et al., 1997). final model refined good
                                                                        geometry statistics, checked MOLPROBITY
bloodstream form T. brucei
                                                                        outliers Ramachandran plot. Final data infor-
RNAit       (http://trypanofan.path.cam.ac.uk/software/RNAit.           mation Table 2. TbPMM residues html; Redmond et al., 2003) used identify suitable               paper numbered start methionine.
RNAi internal coding sequences TbPMM (Tb927.10.6440,
nt. 204â€“667) TbPAGM (Tb927.8.980, nt. 676â€“1172). 464 nt (TbPMM) 497 bp (TbPAGM) fragments, contain-                  Production antibodies cell localization TbPMM
ing XhoI BamHI restriction sites 5â€² 3â€² respec-         TbPAGM immunofluorescence
tively, synthesized Dundee Cell Products cloned p2T7TABlue (Alibu et al., 2005) using XhoI         adult Balb/c mice used raise polyclonal antibod- BamHI sites generate p2T7-TbPMM p2T7-                        ies E. coli overexpressed untagged TbPMM
TbPAGM. constructs digested NotI, precipi-              protein Freundâ€™s complete adjuvant. animal
tated, washed 70  ethanol redissolved sterile               received immunizations Freundâ€™s incomplete
water, used T. brucei transformation                adjuvant 2 months. pool mice sera used
Amaxa nucleofection previously described (Burkard et al.,            Western blots immunofluorescence. Similar proce-
2007). final constructs verified sequencing (DNA            dures performed TbPAGM.
Sequencing Service, College Life Sciences, University                immunofluorescence experiments, wild type blood-
Dundee) transformation.                                          stream form T. brucei cells grown HMI-9T medium
                                                                        (Hirumi Hirumi, 1994; Greig et al., 2009) density 1
                                                                        2 Â¥ 106 cells ml-1, harvested centrifugation 800 g Sugar nucleotide analysis                                               10 min 4Â°C resuspended trypanosome dilution
                                                                        buffer (20 mM Na2HPO4, 2 mM NaH2PO4, 5 mM KCl, 80 mM
Sugar nucleotide extraction analysis performed              NaCl, 1 mM MgSO4, 20 mM glucose pH 7.8) density previously described (Turnock Ferguson, 2007). Briefly,             2 Â¥ 107 cells ml-1. Aliquots (10 ml) placed 13 mm pre-
cells pelleted centrifugation, washed ice-cold               cooled coverslips inside 12 plate, covered, incubated phosphate buffer saline lysed 70  ethanol                 15 min 4Â°C subsequently fixed 1 ml freshly pre-
presence 20 pmol GDP-glucose internal standard                pared 4  paraformaldehyde phosphate-buffered saline
(Sigma). lysate centrifuged remove insoluble                 (PBS) 30 min 4Â°C followed washes 1 ml material supernatant extracted butan-1-ol               PBS. Cells permeabilized 0.1  Triton X-100 remove lipids. Sugar nucleotides extracted                PBS 10 min room temperature. Samples resulting aqueous phase using EnviCarb graphitized carbon               blocked 5  fish skin gelatin (FSG) PBS containing 10 
columns (Supelco) previously described (Rabina et al.,               normal goat serum. coverslips incubated humid

                                                                  Â© 2012 Blackwell Publishing  Molecular Microbiology, 85, 513â€“534
                                                                                       PMM, PAGM phosphoglucomutase activity T. brucei 531

chamber 1:1000 mouse anti-TbPMM mixed              5 ml pooled mice anti-TbPMM sera added 1:2000 rabbit anti-glyceraldehyde-3-phosphate dehydroge-            supernatant incubated 1 h 4Â°C. Subsequently,
nase (GAPDH) antiserum 1:4000 rabbit anti-enolase anti-          50 ml protein G Dynabeads (Invitrogen) added serum diluted 1  FSG PBS, 0.05  Triton X-100.            incubated 1 h 4Â°C. beads recovered anti-GAPDH anti-enolase kindly provided Paul            placing magnet 2 min washed times Michels (Catholic University Louvain, Belgium). Samples          cold 20 mM Tris-HCl pH 7.2, 0.15 M NaCl, 0.03  SDS subsequently washed 1  FSG PBS, 0.05                   1  Triton X-100. beads boiled SDS sample
Triton X-100 incubated 50 ml 1:500 diluted Alexa        buffer 0.1 M DTT, run 4â€“12  Nupage gel 488-conjugated goat anti-mouse IgG 1:500 diluted Alexa          Western blotted described 
594-conjugated goat anti-rabbit IgG 1 h. Coverslips washed mounted glass slides drop Hydro-
mount containing 2.5  DABCO left set dark         Western blot anti-TbPAGM anti-sVSG
30 min. Microscopy performed Zeiss LSM 510
META confocal microscope.                                           TbPAGM RNAi cells induced tetracycline 2
                                                                    3 days, lysed SDS sample buffer, loaded (5 Â¥ 106 cell
                                                                    equivalents lane) SDS-PAGE gel blotted nitro-
Digitonin latency Western blotting                              cellulose. membrane blocked 2  (w/v) FSG                                                                     blocking buffer described developed 1:1000
Digitonin latency performed previously reported              mouse anti-TbPAGM mixed 1:4000 rabbit anti-aldolase.
(Galland et al., 2007). Briefly, T. brucei bloodstream form cells   membrane washed times 0.1  Tween-20
(2 Â¥ 109 cells) washed twice 10 ml STE buffer          PBS, incubated 1:15 000 donkey anti-mouse green
(250 mM sucrose, 25 mM Tris-HCl pH 7.4 1 mM EDTA)               infrared conjugate (IRDye 800 CW, Licor) mixed 1:20 000 resuspended 1.5 ml STEN (STE containing 0.15 M            donkey anti-rabbit red conjugate (IRDye 680, Licor) NaCl). Aliquots (0.15 ml) treated equal volume         scanned Licor Odyssey Infrared Imaging  digitonin various concentrations presence 0.1 mM       Licor imager software used quantify signal TLCK, 1 mg ml-1 leupeptin, 1 mg ml-1 aprotinin 1 mM             infrared channels gel loading normalized PMSF. Digitonin stock prepared 10 mg ml-1 DMSO            aldolase signal. sVSG analysis, TbPAGM RNAi diluted STEN required concentrations. Complete        cells induced tetracycline 2 3 days
extraction obtained parallel treating equivalent       TbPMM RNAi cells 2 days, lysed number cells 0.1  Triton X-100 STEN. lysates         SDS sample buffer, loaded (5 Â¥ 106 cell equivalents lane) incubated 5 min room temperature                SDS-PAGE gel Western blotted nitrocellulose. insoluble materials removed centrifugation 16 000 g       Licor development described  instead rabbit
2 min. pellets discarded; aliquots superna-         anti-sVSG221 used 1:2000 dilution.
tants run reducing 4â€“12  gradient NuPage gel
(Invitrogen) transferred nitrocellulose Western blot-
ting. Note: Different amounts samples loaded
                                                                    Quantitative reverse transcriptase PCR (qRT-PCR) separate gels antibody Western blot, order detection ECL film exposure linear           RNA extracted using RNeasy RNA extraction kit Western blot development; TbPMM 1 Â¥ 107 cell         (Quiagen). cDNA synthesized 1 mg RNA using
equivalents lane, TbPAGM 5 Â¥ 106 cell equivalents       oligo(dT) random primers qScript cDNA synthe-
lane, aldolase (aldo) 1 Â¥ 105 cell equivalents lane,    sis (Quanta Biosciences), diluted 1 100
PEX13 5 Â¥ 106 lane enolase (eno) 1 Â¥ 105 cell           nuclease-free water. qRT-PCR reactions included 3 ml equivalents lane. membranes blocked               diluted cDNA, SYBR Green Master Mix (Quanta Bio-
0.25  bovine serum albumin, 0.05  Tween-20 (Sigma),                 sciences), 0.6 mM forward (atgagggctttgataaagcgagc)
0.15 M NaCl 50 mM Tris-HCl pH 7.4. membranes            reverse (cgtccgagttgctcaacctgc) gene-specific primers.
probed parallel following antibodies 1:1000 diluted     Amplification carried iCycler iQ5 PCR thermal
mouse anti-TbPMM, 1:1000 mouse anti-TbPAGM, 1:4000                  cycler (Bio-Rad). Mean standard deviation deter-
rabbit anti-aldolase, 1:5000 rabbit anti-Pex13 1:5000 rabbit     mined combining replicate analyses.
anti-enolase 1 h 37Â°C. membranes washed incubated 1 h room temperature 1:100 000 goat
anti-mouse goat anti-rabbit horseradish peroxidase conju-        Acknowledgements
gate. washing, membranes developed chemiluminescent detection (Super Signal WestPico, Thermo           authors like thank Mark Agacan Uni-
Scientific) film (Hyperbond ECL, GE Healthcare).                versity Dundee Proteomics Facility (Wellcome Strategic
   immunoprecipitation native TbPMM  check        Award 083481) performing AUC proteomics
mono-specificity), 2 Â¥ 108 T. brucei bloodstream form cells         experiments Alan R. Prescott (Division Cell Signalling lysed 1  (w/v) SDS 20 mM Tris-HCl pH 6.8             Immunology, University Dundee) generous help
taining 0.1 M DTT heated 50Â°C 15 min. SDS            microscopy. like thank Michael
diluted 0.03  1  (w/v) Triton X-100 20 mM Tris-          Urbaniak SILAC data Alan Fairlamb high
HCl pH 6.8 0.15 M NaCl presence 0.1 mM               substrate inhibition equation. grateful Daan van
TLCK, 1 mg ml-1 leupeptin, 1 mg ml-1 aprotinin 1 mM             Aalten providing reagents Paul Michels providing
PMSF. insoluble material removed centrifugation,         anti-GAPDH anti-enolase antibodies.

Â© 2012 Blackwell Publishing  Molecular Microbiology, 85, 513â€“534
 532 G. Bandini et al. äŠ?

References                                                                  Crabtree, J., Aggarwal, G., et al. (2005b) Comparative
                                                                            genomics trypanosomatid parasitic protozoa. Science
Alibu, V.P., Storm, L., Haile, S., Clayton, C., Horn, D.                309: 404â€“409.
  (2005) doubly inducible RNA interference               Engstler, M., Weise, F., Bopp, K., Grunfelder, C.G., Gunzel,
  rapid RNAi plasmid construction Trypanosoma brucei.                    M., Heddergott, N., Overath, P. (2005) membrane-
   Mol Biochem Parasitol 139: 75â€“82.                                        bound histidine acid phosphatase TbMBAP1 essential
Allen, K.N., Dunaway-Mariano, D. (2004) Phosphoryl                      endocytosis membrane recycling Trypanosoma
   group transfer: evolution catalytic scaffold. Trends                brucei. J Cell Sci 118: 2105â€“2118.
   Biochem Sci 29: 495â€“503.                                               Favre, E., Wissmann, B., Welburn, S., Lutumba, P.
Aslett, M., Aurrecoechea, C., Berriman, M., Brestelli, J.,                  (2008) burden human African trypanosomiasis.
   Brunk, B.P., Carrington, M., et al. (2010) TriTrypDB: func-            PLoS Negl Trop Dis 2: e333.
   tional genomic resource Trypanosomatidae. Nucleic              Fernandez-Sorensen, , Carlson, D.M. (1971) Purifica-
   Acids Res 38: D457â€“D462.                                                 tion properties phosphoacetylglucosamine mutase.
Barrett, M.P., Tetaud, E., Seyfang, , Bringaud, F., Baltz,            J Biol Chem 246: 3485â€“3493.
   T. (1995) Functional expression characterization            Flores-DÃ­az, M., Alape-GirÃ³n, , Persson, B., Pollesello, P.,
   Trypanosoma brucei procyclic glucose transporter, THT2.                  Moos, M., von Eichel-Streiber, C., et al. (1997) Cellular
   Biochem J 312  3): 687â€“691.                                         UDP-glucose deficiency caused single point mutation
Berriman, M., Ghedin, E., Hertz-Fowler, C., Blandin, G.,                    UDP-glucose pyrophosphorylase gene. J Biol Chem
   Renauld, H., Bartholomeu, D.C., et al. (2005) genome                 272: 23784â€“23791.
   African trypanosome Trypanosoma brucei. Science                 Freeze, H., Elbein,  (2008) Glycosylation precursors.    309: 416â€“422.                                                            Essentials Glycobiology. Varki, , Cummings, R., Esko,
Boles, E., Liebetrau, W., Hofmann, M., Zimmermann,                      J., Freeze, H., Stanley, P., Bertozzi, C., et al. (eds). New
   F.K. (1994) family hexosephosphate mutases Sac-                  York, NY, USA: Cold Spring Harbour Laboratory Press, pp.
   charomyces cerevisiae. Eur J Biochem 220: 83â€“96.                         47â€“62.
Borst, P., Sabatini, R. (2008) Base J: discovery, biosyn-             Galland, N., Demeure, F., Hannaert, V., Verplaetse, E., Ver-
   thesis, possible functions. Annu Rev Microbiol 62:                   tommen, D., Smissen, P.V.D., et al. (2007) Characteriza-
   235â€“251.                                                                 tion role receptors PEX5 PEX7 Burkard, G., Fragoso, C.M., Roditi,  (2007) Highly effi-              import proteins glycosomes Trypanosoma brucei.
   cient stable transformation bloodstream forms Trypa-               Biochim Biophys Acta 1773: 521â€“535.
   nosoma brucei. Mol Biochem Parasitol 153: 220â€“223.                     Galland, N., Walque, S., Voncken, F.G.J., Verlinde, C.L.
Caramelo, J.J., Castro, O , Prat-Gay, G., Parodi, J.             M.J., Michels, P M. (2010) internal sequence
   (2004) endoplasmic reticulum glucosyltransferase rec-                targets Trypanosoma brucei triosephosphate isomerase    ognizes nearly native glycoprotein folding intermediates.                glycosomes. Mol Biochem Parasitol 171: 45â€“49.
   J Biol Chem 279: 46280â€“46285.                                          Greig, N., Wyllie, S., Patterson, S., Fairlamb, H. (2009)
Chenna, R., Sugawara, H., Koike, T., Lopez, R., Gibson, T.J.,               comparative study methyglyoxal metabolism    Higgins, D.G., Thompson, J.D. (2003) Multiple                        trypanosomatids. FEBS J 276: 376â€“386.
   sequence alignment Clustal series programs.                Haanstra, J.R., Van Tuijl, , Kessler, P., Reijnders, W.,
   Nucleic Acids Res 31: 3497â€“3500.                                         Michels, P M., Westerhoff, H.V., et al. (2008) Compart-
Colasante, C., Ellis, M., Ruppert, T., Voncken, F. (2006)               mentation prevents lethal turbo-explosion glycolysis    Comparative proteomics glycosomes bloodstream                    trypanosomes. Proc Natl Acad Sci USA 105: 17718â€“17723.
   form procyclic culture form Trypanosoma brucei                     Hirumi, H., Hirumi, K. (1994) Axenic culture African
   brucei. Proteomics 6: 3275â€“3293.                                         trypanosome bloodstream forms. Parasitol Today 10:
Collet, J.F., Stroobant, V., Pirard, M., Delpierre, G., Van             80â€“84.
   Schaftingen, E. (1998) new class phosphotransferases              Hofmann, M., Boles, E., Zimmermann, F.K. (1994) Char-
   phosphorylated aspartate residue amino-                      acterization essential yeast gene encoding
   terminal DXDX(T/V) motif. J Biol Chem 273: 14107â€“14112.                  N-acetylglucosamine-phosphate mutase. Eur J Biochem
Cross, G  (1996) Antigenic variation trypanosomes:                     221: 741â€“747.
   secrets surface slowly. Bioessays 18: 283â€“291.                         Izquierdo, L., Atrih, , Rodrigues, J , Jones, D.C., Davis, J., Perugini, M , Smith, B.J., Stewart, J.D., Ilg, T.,           Ferguson, M  (2009) Trypanosoma brucei UDP-
   Hodder, N., Handman, E. (2004) Properties GDP-                  glucose:glycoprotein glucosyltransferase unusual sub-
   mannose pyrophosphorylase, critical enzyme drug                    strate specificity protects parasite stress.
   target Leishmania mexicana. J Biol Chem 279: 12462â€“                   Eukaryot Cell 8: 230â€“240.
   12468.                                                                 Jaroszewski, L., Rychlewski, L., Li, , Li, W., Godzik, 
Denton, H., Fyffe, S., Smith, T.K. (2010) GDP-mannose                   (2005) FFAS03: server profile-profile sequence
   pyrophosphorylase essential bloodstream form                alignments. Nucleic Acids Res 33: W284â€“W288.
   Trypanosoma brucei. Biochem J 425: 603â€“614.                            Kato, N., Mueller, C.R., Wessely, V., Lan, Q., Chris-
El-Sayed, N.M., Myler, P.J., Bartholomeu, D.C., Nilsson, D.,                tensen, B.M. (2005) Aedes aegypti phosphohexomutases
  Aggarwal, G., Tran, N., et al. (2005a) genome                       uridine diphosphate-hexose pyrophosphorylases:
  sequence Trypanosoma cruzi, etiologic agent chagas                  comparison primary sequences, substrate specificities
   disease. Science 309: 409â€“415.                                           temporal transcription. Insect Mol Biol 14: 615â€“
El-Sayed, N.M., Myler, P.J., Blandin, G.L., Berriman, M.,                   624.

                                                                    Â© 2012 Blackwell Publishing  Molecular Microbiology, 85, 513â€“534
                                                                                        PMM, PAGM phosphoglucomutase activity T. brucei 533

Kedzierski, L., Malby, R.L., Smith, B.J., Perugini, M ,           Pays, E., Nolan, D.P. (1998) Expression function   Hodder, N., Ilg, T., et al. (2006) Structure Leishmania        surface proteins Trypanosoma brucei. Mol Biochem
  mexicana phosphomannomutase highlights similarities                 Parasitol 91: 3â€“36.
  human isoforms. J Mol Biol 363: 215â€“227.                     Peck, R.F., Shiflett, M., Schwartz, K.J., McCann, ,
Kepes, F., Schekman, R. (1988) yeast SEC53 gene               Hajduk, S.L., Bangs, J.D. (2008) LAMP-like
  encodes phosphomannomutase. J Biol Chem 263: 9155â€“                  protein p67 plays essential role lysosome   9161.                                                               African trypanosomes. Mol Microbiol 68: 933â€“946.
Lackovic, K., Parisot, J.P., Sleebs, N., Baell, J.B., Debien, L.,   Penha, L.L., MendonÃ Previato, L., Previato, J.O., Scharf-
  Watson, K.G., et al. (2010) Inhibitors Leishmania GDP-           stein, J., Heise, N., Lima, P. (2005) Cloning   mannose pyrophosphorylase identified high-throughput             characterization phosphoglucomutase Trypano-
  screening small-molecule chemical library. Antimicrob            soma cruzi functional complementation Saccha-
  Agents Chemother 54: 1712â€“1719.                                     romyces cerevisiae PGM null mutant. Glycobiology 15:
Macrae, J , Obado, S.O., Turnock, D.C., Roper, J.R.,                1359â€“1367.
  Kierans, M., Kelly, J.M., et al. (2006) suppression        Penha, L.L., Santâ€™Anna, C.B., MendonÃ Previato, L.,
  galactose metabolism Trypanosoma cruzi epimastigotes             Cunha-e-Silva, N.L., Previato, J.O., Lima, P. (2009)
  causes changes cell surface molecular architecture           Sorting phosphoglucomutase glycosomes Trypano-
  cell morphology. Mol Biochem Parasitol 147: 126â€“136.                soma cruzi mediated internal domain. Glycobiol-
MariÃ±o, K., Sampaio-GÃ¼ther, M.L., Wernimont, K., Amani,             ogy 19: 1462â€“1472.
  M., Hui, R., Ferguson, M  (2010) Identification, sub-       Pirard, M., Collet, J.F., Matthijs, G., Van Schaftingen, E.
  cellular localization, biochemical properties high-             (1997) Comparison PMM1 phosphomannomu-
  resolution crystal structure Trypanosoma brucei UDP-             tases expressed rat liver human cells. FEBS Lett
  glucose pyrophosphorylase. Glycobiology 20: 1619â€“                   411: 251â€“254.
  1630.                                                             Pirard, M., Achouri, Y., Collet, J.F., Schollen, E., Matthijs, G.,
MariÃ±o, K., GÃ¼ther, M.L.S., Wernimont, K., Qiu, W., Hui, R.,        Van Schaftingen, E. (1999) Kinetic properties tis-
  Ferguson, M J. (2011) Characterization, localization,         sular distribution mammalian phosphomannomutase
  essentiality high-resolution crystal structure               isozymes. Biochem J 339  1): 201â€“207.
  Glucosamine-6-phosphate N-acetyltransferase Trypa-           Qian, W., Yu, C., Qin, H., Liu, X., Zhang, , Johansen, E.,
  nosoma brucei. Eukaryot Cell 10: 985â€“997.                           Wang, D. (2007) Molecular functional analysis Mehlert, , Ferguson, M  (2007) Structure gly-          phosphomannomutase (PMM) higher plants   cosylphosphatidylinositol anchor Trypanosoma                 genetic evidence involvement PMM ascorbic
  brucei transferrin receptor. Mol Biochem Parasitol 151:             acid biosynthesis Arabidopsis Nicotiana benthami-
  220â€“223.                                                            ana. Plant J 49: 399â